Literature DB >> 638050

The decrease of hyaluronate synthesis by anti-inflammatory steroids in vitro.

H Saarni, V K Hopsu-Havu.   

Abstract

The effect of anti-inflammatory steroids (prednisolone and derivatives of hydrocortisone, dexamethasone and betamethasone) on the synthesis of hyaluronic acid and sulphated glycosaminoglycans in human skin fibroblast culture was studied. The concentrations of steroids varied between 1 x 10(-10)M and 1 x 10(-6)M. All tested steroids decreased the synthesis of hyaluronic acid to the same final level which was about 40--50% of the controls, but the concentrations required varied between different steroids. The relative inhibitory potencies of the steroids were calculated based on concentrations needed to decrease the synthesis of hyaluronate. When the inhibitory potency of hydrocortisone was calculated as one, the values of the other steroids were: prednisolone 5, hydrocortisone 17- butyrate 20, betamethasone alcohol 30, dexamethasone alcohol 38, betamethasone 17-valerate 350--400, dexamethasone monosodium phosphate and betamethasone disodium phosphate over 400. Hydrocortisone sodium succinate was as potent an inhibitor of hyaluronate synthesis as hydrocortisone alcohol. None of the tested steroids affected the synthesis of sulphated glycosaminoglycans at these concentrations. The changes ovbserved in glycosaminoglycans in the medium were in accordance with the changes in the cell layer. The possible significance of hyaluronate synthesis inhibition by anti-inflammatory steroids is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638050     DOI: 10.1111/j.1365-2133.1978.tb06539.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

1.  Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy.

Authors:  Stefanie Schoepe; Heike Schäcke; Khusru Asadullah
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 2.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

3.  Mechanical properties of keloids in vivo during treatment with intralesional triamcinolone acetonide.

Authors:  T Krusche; W I Worret
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy.

Authors:  A Engström-Laurent; R Hällgren
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

5.  Effects of five anti-inflammatory steroids on DNA synthesis by normal skin fibroblasts in vitro.

Authors:  K Saarni; M Jalkanen; V K Hopsu-Havu
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

6.  Effect of betamethasone on airway obstruction and bronchial response to salbutamol in prednisolone resistant asthma.

Authors:  B Grandordy; N Belmatoug; A Morelle; D De Lauture; J Marsac
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

7.  The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment.

Authors:  M M Smith; P Ghosh
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

8.  Longitudinal in vivo tracking of adverse effects following topical steroid treatment.

Authors:  Andrew J Bower; Zane Arp; Youbo Zhao; Joanne Li; Eric J Chaney; Marina Marjanovic; Angela Hughes-Earle; Stephen A Boppart
Journal:  Exp Dermatol       Date:  2016-02-13       Impact factor: 3.960

9.  Epidermal thinning: evaluation of commercial corticosteroids.

Authors:  R Wrench
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

10.  Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy.

Authors:  Hanne Norsgaard; Sandrine Kurdykowski; Pascal Descargues; Tatiana Gonzalez; Troels Marstrand; Georg Dünstl; Mads Røpke
Journal:  Arch Dermatol Res       Date:  2014-07-16       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.